2m 2m 2m 2m 2m 2m 2m
TANGO THERAPETCS (TNGX)
NASDAQ
$25.72+$1.42 (+5.84%)
Price as of Nov 11, 2026 7:30 PM EST- $4.1BMarket Cap
- 189.98%1-Year Change
- BiotechnologyIndustry
TANGO THERAPETCS (TNGX)
$25.72+$1.42 (+5.84%)
Top Holders
Institutional
Mutual Funds
Holder | Ownership %
| Shares Held | Change (Shares, %) | Report Date |
|---|---|---|---|---|
RTW INVESTMENTS, LP | 8.24% | 13.9M | +600,000 (+4.32%) | Jun 30, 2026 |
BLACKROCK, INC. | 7.38% | 12.4M | +3.7M (+29.67%) | Jun 30, 2026 |
FMR LLC | 7.31% | 12.3M | +2.4M (+19.68%) | Jun 30, 2026 |
FARALLON CAPITAL MANAGEMENT LLC | 7.28% | 12.3M | +3.2M (+25.90%) | Jun 30, 2026 |
BOXER CAPITAL MANAGEMENT, LLC | 6.45% | 10.9M | 0 (0.00%) | Jun 30, 2026 |
ECOR1 CAPITAL, LLC | 6.30% | 10.6M | 0 (0.00%) | Sep 30, 2025 |
GOLDMAN SACHS GROUP INC | 5.92% | 10.0M | +4.9M (+49.14%) | Jun 30, 2026 |
Holder | Ownership %
| Shares Held | Change (Shares, %) | Report Date |
|---|---|---|---|---|
VANGUARD INDEX FUNDS | 3.42% | 5.8M | +735,100 (+12.76%) | Jun 30, 2026 |
FIDELITY MT VERNON STREET TRUST | 2.55% | 4.3M | +532,000 (+12.39%) | Aug 31, 2026 |
FIDELITY SELECT PORTFOLIOS | 1.48% | 2.5M | +160,700 (+6.43%) | Aug 31, 2026 |
FIDELITY SALEM STREET TRUST | 1.10% | 1.9M | +1.7M (+92.90%) | Jul 31, 2026 |
T. Rowe Price New Horizons Fund, Inc. | 0.92% | 1.5M | +1.5M (+100.00%) | Jun 30, 2026 |
T. Rowe Price Health Sciences Fund, Inc. | 0.83% | 1.4M | +762,807 (+54.44%) | Jun 30, 2026 |
Federated Hermes Equity Funds | 0.82% | 1.4M | +1.4M (+100.00%) | Jul 31, 2026 |
Current Ownership Distribution
- Institutions2.1B (86.70%)
- Mutual Funds259.7M (10.96%)
- Insiders55.5M (2.34%)
- Other0 (0.00%)
Insider Transactions
- 2.34% (55.5M)Current InsiderOwnership (%, shares)
- 0Number of InsiderBuying (last 12 months)
- $0.00Amount of InsiderBuying (last 12 months)
- 2Number of InsiderSelling (last 12 months)
- $31.7MAmount of InsiderSelling (last 12 months)
Insider Name & Title | Type | Date
| Transaction Value | Shares | Share Price | Shares After Transactions |
|---|---|---|---|---|---|---|
Newcomb Jessica Principal Accounting Officer | Sell | Nov 02, 2026 | $124,107.40 | 5,571 | $22.28 | 53,550 |
Newcomb Jessica Principal Accounting Officer | Sell | Nov 02, 2026 | $33,553.14 | 1,460 | $22.98 | 52,090 |
Crystal Adam President, R&D | Exempt | Oct 01, 2026 | $0.00 | 27,000 | $0.00 | 233,040 |
Crystal Adam President, R&D | Exempt | Oct 01, 2026 | $140,400.00 | 27,000 | $5.20 | 142,743 |
Crystal Adam President, R&D | Sell | Oct 01, 2026 | $645,604.08 | 26,400 | $24.45 | 116,343 |
Crystal Adam President, R&D | Sell | Oct 01, 2026 | $15,192.00 | 600 | $25.32 | 115,743 |
Newcomb Jessica Principal Accounting Officer | Sell | Sep 22, 2026 | $15,962.03 | 700 | $22.80 | 66,621 |
Newcomb Jessica Principal Accounting Officer | Sell | Sep 22, 2026 | $122,238.33 | 5,100 | $23.97 | 61,521 |
Newcomb Jessica Principal Accounting Officer | Sell | Sep 22, 2026 | $60,412.32 | 2,400 | $25.17 | 59,121 |
Crystal Adam President, R&D | Exempt | Aug 03, 2026 | $0.00 | 27,000 | $0.00 | 287,040 |
Crystal Adam President, R&D | Exempt | Aug 03, 2026 | $140,400.00 | 27,000 | $5.20 | 142,743 |
Crystal Adam President, R&D | Sell | Aug 03, 2026 | $141,100.30 | 5,267 | $26.79 | 137,476 |
Crystal Adam President, R&D | Sell | Aug 03, 2026 | $594,417.11 | 21,733 | $27.35 | 115,743 |
Crystal Adam President, R&D | Exempt | Jul 01, 2026 | $0.00 | 27,000 | $0.00 | 314,040 |
Crystal Adam President, R&D | Exempt | Jul 01, 2026 | $140,400.00 | 27,000 | $5.20 | 142,743 |
Crystal Adam President, R&D | Sell | Jul 01, 2026 | $575,961.97 | 19,629 | $29.34 | 123,114 |
Crystal Adam President, R&D | Sell | Jul 01, 2026 | $222,946.21 | 7,371 | $30.25 | 115,743 |
Crystal Adam President, R&D | Exempt | Apr 01, 2026 | $0.00 | 27,000 | $0.00 | 433,500 |
Crystal Adam President, R&D | Exempt | Apr 01, 2026 | $140,400.00 | 27,000 | $5.20 | 139,622 |
Crystal Adam President, R&D | Sell | Apr 01, 2026 | $572,478.30 | 27,000 | $21.20 | 112,622 |
Crystal Adam President, R&D | Sell | Mar 05, 2026 | $303,765.00 | 20,251 | $15.00 | 112,622 |
Crystal Adam President, R&D | Sell | Feb 03, 2026 | $223,707.98 | 18,251 | $12.26 | 187,419 |
Crystal Adam President, R&D | Sell | Feb 03, 2026 | $2,592.32 | 201 | $12.90 | 187,218 |
Crystal Adam President, R&D | Award | Feb 02, 2026 | $0.00 | 284,760 | $0.00 | 284,760 |
Crystal Adam President, R&D | Award | Feb 02, 2026 | $0.00 | 47,460 | $0.00 | 205,670 |
Peters Malte President & CEO | Award | Jan 08, 2026 | $0.00 | 1.6M | $0.00 | 1.6M |
Peters Malte President & CEO | Award | Jan 08, 2026 | $0.00 | 350,000 | $0.00 | 367,500 |
Lee Sung | Award | Jan 02, 2026 | $0.00 | 60,000 | $0.00 | 60,000 |
Lee Sung | Award | Jan 02, 2026 | $0.00 | 10,000 | $0.00 | 10,000 |
Peters Malte | Award | Nov 03, 2025 | $0.00 | 150,000 | $0.00 | 150,000 |